CWM
GILD icon

Consultiva Wealth Management’s Gilead Sciences GILD Stock Holding History

Consultiva Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.6K Hold
198
– – 0.08% 130
2025
Q4 		$24.3K Hold
198
– – 0.07% 141
2025
Q3 		$22K Hold
198
– – 0.06% 154
2025
Q2 		$22K Hold
198
– – 0.07% 149
2025
Q1 		$22.2K Hold
198
– – 0.08% 148
2024
Q4 		$18.3K Buy
+198
New +$17.8K 0.09% 100

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Consultiva Wealth Management's GILD Position: Q1 2026 in Review

Consultiva Wealth Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 198 shares worth $27.6K. The position accounts for 0.08% of the portfolio, ranked #130.

Consultiva Wealth Management first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Consultiva Wealth Management held 198 shares of Gilead Sciences worth $27.6K as of Q1 2026.
  • Consultiva Wealth Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.08% of Consultiva Wealth Management's portfolio in Q1 2026, its #130 holding.
  • Consultiva Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Consultiva Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.